XML 48 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Schedule of Selected Financial Data
(1)
The long term acute care segment includes $2.7 million, $24.4 million, and $9.8 million in real estate assets held for sale on December 31, 2015, 2016, and 2017, respectively.
(2)
Total assets were retrospectively conformed to reflect the adoption ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which resulted in a reduction to total assets of $23.8 million.
(3)
The selected financial data for the Company’s Concentra segment begins as of June 1, 2015, which is the date the Concentra acquisition was consummated.
(4)
The outpatient rehabilitation segment includes the operating results of the Company’s contract therapy businesses through March 31, 2016 and Physiotherapy beginning March 4, 2016.
The following tables summarize selected financial data for the Company’s reportable segments. The segment results of Holdings are identical to those of Select.
 
Year Ended December 31, 2015
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation
 
Concentra(3)
 
Other
 
Total
 
(in thousands)
Net revenue
$
1,902,776

 
$
444,005

 
$
810,009

 
$
585,222

 
$
724

 
$
3,742,736

Adjusted EBITDA
258,223

 
69,400

 
98,220

 
48,301

 
(74,979
)
 
399,165

Total assets(1)
1,954,823

 
470,290

 
548,242

 
1,311,631

 
103,692

 
4,388,678

Capital expenditures
39,784

 
86,230

 
17,768

 
26,771

 
12,089

 
182,642

 
Year Ended December 31, 2016
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation(4)
 
Concentra
 
Other
 
Total
 
(in thousands)
Net revenue
$
1,785,164

 
$
504,318

 
$
995,374

 
$
1,000,624

 
$
541

 
$
4,286,021

Adjusted EBITDA
224,609

 
56,902

 
129,830

 
143,009

 
(88,543
)
 
465,807

Total assets(1)(2)
1,910,013

 
621,105

 
969,014

 
1,313,176

 
107,318

 
4,920,626

Capital expenditures
48,626

 
60,513

 
21,286

 
15,946

 
15,262

 
161,633

 
Year Ended December 31, 2017
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation
 
Concentra
 
Other
 
Total
 
(in thousands)
Net revenue
$
1,756,243

 
$
631,777

 
$
1,020,848

 
$
1,034,035

 
$
700

 
$
4,443,603

Adjusted EBITDA
252,679

 
90,041

 
132,533

 
157,561

 
(94,822
)
 
537,992

Total assets(1)
1,848,783

 
868,517

 
954,661

 
1,340,919

 
114,286

 
5,127,166

Capital expenditures
49,720

 
96,477

 
27,721

 
28,912

 
30,413

 
233,243

Schedule of Reconciliation of Adjusted EBITDA to Income Before Taxes
(3)
The selected financial data for the Company’s Concentra segment begins as of June 1, 2015, which is the date the Concentra acquisition was consummated.
(4)
The outpatient rehabilitation segment includes the operating results of the Company’s contract therapy businesses through March 31, 2016 and Physiotherapy beginning March 4, 2016.
A reconciliation of Adjusted EBITDA to income before income taxes is as follows:
 
Year Ended December 31, 2015
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation
 
Concentra(3)
 
Other
 
Total
 
(in thousands)
Adjusted EBITDA
$
258,223

 
$
69,400

 
$
98,220

 
$
48,301

 
$
(74,979
)
 
 

Depreciation and amortization
(45,234
)
 
(8,758
)
 
(13,053
)
 
(33,644
)
 
(4,292
)
 
 

Stock compensation expense

 

 

 
(1,016
)
 
(13,663
)
 
 

Concentra acquisition costs

 

 

 
(4,715
)
 

 
 
Income (loss) from operations
$
212,989

 
$
60,642

 
$
85,167

 
$
8,926

 
$
(92,934
)
 
$
274,790

Equity in earnings of unconsolidated subsidiaries
 

 
 
 
 

 
 

 
 

 
16,811

Non-operating gain
 
 
 
 
 
 
 
 
 
 
29,647

Interest expense
 

 
 
 
 

 
 

 
 

 
(112,816
)
Income before income taxes
 

 
 
 
 

 
 

 
 

 
$
208,432

 
Year Ended December 31, 2016
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation(4)
 
Concentra
 
Other
 
Total
 
(in thousands)
Adjusted EBITDA
$
224,609

 
$
56,902

 
$
129,830

 
$
143,009

 
$
(88,543
)
 
 

Depreciation and amortization
(43,862
)
 
(12,723
)
 
(22,661
)
 
(60,717
)
 
(5,348
)
 
 

Stock compensation expense

 

 

 
(770
)
 
(16,643
)
 
 

Physiotherapy acquisition costs

 

 

 

 
(3,236
)
 
 

Income (loss) from operations
$
180,747

 
$
44,179

 
$
107,169

 
$
81,522

 
$
(113,770
)
 
$
299,847

Loss on early retirement of debt
 
 
 
 
 
 
 
 
 
 
(11,626
)
Equity in earnings of unconsolidated subsidiaries
 

 
 
 
 

 
 

 
 

 
19,943

Non-operating gain
 

 
 
 
 

 
 

 
 

 
42,651

Interest expense
 

 
 
 
 

 
 

 
 

 
(170,081
)
Income before income taxes
 

 
 
 
 

 
 

 
 

 
$
180,734

 
Year Ended December 31, 2017
 
Long Term Acute Care
 
Inpatient Rehabilitation
 
Outpatient
Rehabilitation
 
Concentra
 
Other
 
Total
 
(in thousands)
Adjusted EBITDA
$
252,679

 
$
90,041

 
$
132,533

 
$
157,561

 
$
(94,822
)
 
 

Depreciation and amortization
(45,743
)
 
(20,176
)
 
(24,607
)
 
(61,945
)
 
(7,540
)
 
 

Stock compensation expense

 

 

 
(993
)
 
(18,291
)
 
 

U.S. HealthWorks acquisition costs

 

 

 
(2,819
)
 

 
 

Income (loss) from operations
$
206,936

 
$
69,865

 
$
107,926

 
$
91,804

 
$
(120,653
)
 
$
355,878

Loss on early retirement of debt
 

 
 
 
 

 
 

 
 

 
(19,719
)
Equity in earnings of unconsolidated subsidiaries
 

 
 
 
 

 
 

 
 

 
21,054

Non-operating loss
 

 
 
 
 

 
 

 
 

 
(49
)
Interest expense
 

 
 
 
 

 
 

 
 

 
(154,703
)
Income before income taxes
 

 
 
 
 

 
 

 
 

 
$
202,461

_______________________________________________________________________________
(1)
The long term acute care segment includes $2.7 million, $24.4 million, and $9.8 million in real estate assets held for sale on December 31, 2015, 2016, and 2017, respectively.
(2)
Total assets were retrospectively conformed to reflect the adoption ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which resulted in a reduction to total assets of $23.8 million.
(3)
The selected financial data for the Company’s Concentra segment begins as of June 1, 2015, which is the date the Concentra acquisition was consummated.
(4)
The outpatient rehabilitation segment includes the operating results of the Company’s contract therapy businesses through March 31, 2016 and Physiotherapy beginning March 4, 2016.